Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
8.55
+0.24 (2.89%)
At close: Dec 5, 2025, 4:00 PM EST
8.46
-0.09 (-1.05%)
After-hours: Dec 5, 2025, 7:57 PM EST
Nuvation Bio Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Nuvation Bio stock have an average target of 9.63, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 12.63% from the current stock price of 8.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nuvation Bio stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +16.96% | Dec 1, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +28.65% | Nov 24, 2025 |
| Citizens | Citizens | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +16.96% | Nov 20, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +40.35% | Nov 19, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -6.43% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
30.17M
from 7.87M
Increased by 283.17%
Revenue Next Year
133.03M
from 30.17M
Increased by 340.98%
EPS This Year
-0.67
from -2.11
EPS Next Year
-0.57
from -0.67
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 48.1M | 220.1M | ||||
| Avg | 30.2M | 133.0M | ||||
| Low | 17.6M | 26.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 510.8% | 629.5% | ||||
| Avg | 283.2% | 341.0% | ||||
| Low | 124.1% | -11.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.63 | -0.20 | ||
| Avg | -0.67 | -0.57 | ||
| Low | -0.69 | -0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.